Update for Members and Associates on COVID-19

Many Speech-Language & Audiology Canada (SAC) members and associates are facing professional, financial and personal challenges associated with the rapidly changing COVID-19 pandemic. As health care professionals, many of you are providing front-line care. SAC wishes to thank you for your commitment to your patients, clients and your profession during these most trying of times.
 

 

Members and associates may find the following resources helpful when making decisions about their professional practice in light of COVID-19. Click on the buttons below to jump to each list of resources:

 

                        

 


SAC strongly advises that members who are registered with a provincial regulatory body follow guidance provided by their regulatory body. Below are some other resources to help guide clinical practice and telepractice during this pandemic. 

 

Infection Prevention & Control

 

Communication Supports

  • SAC has gathered communication support resources to assist members and associates in communicating with patients who may need additional support due to speech-related disabilities (updated April 6, 2020).

 

End of Life Care

  • SAC has gathered resources on end of life care to support members and associates in communicating with patients at end of life (updated March 30, 2020)

 

Guidance for Speech-Language Pathologists Providing Dysphagia, Tracheostomy and Laryngectomy Management

 

Telepractice

 

Telepractice and Extended Health Insurance Benefits

 


 


SAC has also reached out to our insurance partner, BMS for information on the impact of COVID-19 on our members and associates:

 

ADDITIONAL RESOURCES FROM BMS

 


SAC has gathered resources developed by the Canadian Psychology Association and other organizations to provide insight and tips on maintaining mental health during this pandemic:

 


PLEASE NOTE: SAC staff are currently working remotely and are available by email. SAC will continue to provide services to members and associates.